These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1406 related articles for article (PubMed ID: 26384753)

  • 21. Outcomes of surgical aortic valve replacement in moderate risk patients: implications for determination of equipoise in the transcatheter era.
    Iturra SA; Suri RM; Greason KL; Stulak JM; Burkhart HM; Dearani JA; Schaff HV
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):127-32. PubMed ID: 24094915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sutureless versus Transfemoral Transcatheter Aortic Valve Implant: A Propensity Score Matching Study.
    Santarpino G; Vogt F; Pfeiffer S; Dell'Aquila AM; Jessl J; Cuomo F; von Wardenburg C; Fischlein T; Pauschinger M; Schwab J
    J Heart Valve Dis; 2017 May; 26(3):255-261. PubMed ID: 29092108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events following transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis.
    Panchal HB; Ladia V; Desai S; Shah T; Ramu V
    Am J Cardiol; 2013 Sep; 112(6):850-60. PubMed ID: 23756547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sutureless aortic valve replacement as an alternative treatment for patients belonging to the "gray zone" between transcatheter aortic valve implantation and conventional surgery: a propensity-matched, multicenter analysis.
    D'Onofrio A; Messina A; Lorusso R; Alfieri OR; Fusari M; Rubino P; Rinaldi M; Di Bartolomeo R; Glauber M; Troise G; Gerosa G
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1010-6. PubMed ID: 22974713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contemporary Costs Associated With Transcatheter Aortic Valve Replacement: A Propensity-Matched Cost Analysis.
    Ailawadi G; LaPar DJ; Speir AM; Ghanta RK; Yarboro LT; Crosby IK; Lim DS; Quader MA; Rich JB
    Ann Thorac Surg; 2016 Jan; 101(1):154-60; discussion 160. PubMed ID: 26409710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.
    Popma JJ; Adams DH; Reardon MJ; Yakubov SJ; Kleiman NS; Heimansohn D; Hermiller J; Hughes GC; Harrison JK; Coselli J; Diez J; Kafi A; Schreiber T; Gleason TG; Conte J; Buchbinder M; Deeb GM; Carabello B; Serruys PW; Chenoweth S; Oh JK;
    J Am Coll Cardiol; 2014 May; 63(19):1972-81. PubMed ID: 24657695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence, clinical characteristics and outcomes of high-risk patients treated for severe aortic stenosis prior to and after transcatheter aortic valve implantation availability.
    Attias D; Maillet JM; Copie X; Bonnet N; Mesnildrey P; Benvenuti C; Benacerraf M; Scheublé A; Digne F; Stratiev V; Guyon P
    Eur J Cardiothorac Surg; 2015 May; 47(5):e206-12. PubMed ID: 25687453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
    Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of Patients at Estimated Low, Intermediate, and High Risk Undergoing Transcatheter Aortic Valve Implantation for Aortic Stenosis.
    Barbash IM; Finkelstein A; Barsheshet A; Segev A; Steinvil A; Assali A; Ben Gal Y; Vaknin Assa H; Fefer P; Sagie A; Guetta V; Kornowski R
    Am J Cardiol; 2015 Dec; 116(12):1916-22. PubMed ID: 26602076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous implantation of the CoreValve® self-expanding valve prosthesis in patients with severe aortic stenosis and porcelain aorta: medium-term follow-up.
    Pascual I; Avanzas P; Muñoz-García AJ; López-Otero D; Jimenez-Navarro MF; Cid-Alvarez B; del Valle R; Alonso-Briales JH; Ocaranza-Sanchez R; Alfonso F; Hernández JM; Trillo-Nouche R; Morís C
    Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):775-81. PubMed ID: 24773857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimally invasive aortic valve replacement with a sutureless valve through a right anterior mini-thoracotomy versus transcatheter aortic valve implantation in high-risk patients.
    Miceli A; Gilmanov D; Murzi M; Marchi F; Ferrarini M; Cerillo AG; Quaini E; Solinas M; Berti S; Glauber M
    Eur J Cardiothorac Surg; 2016 Mar; 49(3):960-5. PubMed ID: 26113005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial.
    Feldman TE; Reardon MJ; Rajagopal V; Makkar RR; Bajwa TK; Kleiman NS; Linke A; Kereiakes DJ; Waksman R; Thourani VH; Stoler RC; Mishkel GJ; Rizik DG; Iyer VS; Gleason TG; Tchétché D; Rovin JD; Buchbinder M; Meredith IT; Götberg M; Bjursten H; Meduri C; Salinger MH; Allocco DJ; Dawkins KD
    JAMA; 2018 Jan; 319(1):27-37. PubMed ID: 29297076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study.
    D'Errigo P; Barbanti M; Ranucci M; Onorati F; Covello RD; Rosato S; Tamburino C; Santini F; Santoro G; Seccareccia F;
    Int J Cardiol; 2013 Sep; 167(5):1945-52. PubMed ID: 22633667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.
    Mack MJ; Leon MB; Smith CR; Miller DC; Moses JW; Tuzcu EM; Webb JG; Douglas PS; Anderson WN; Blackstone EH; Kodali SK; Makkar RR; Fontana GP; Kapadia S; Bavaria J; Hahn RT; Thourani VH; Babaliaros V; Pichard A; Herrmann HC; Brown DL; Williams M; Akin J; Davidson MJ; Svensson LG;
    Lancet; 2015 Jun; 385(9986):2477-84. PubMed ID: 25788234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical performance of a sutureless aortic bioprosthesis: five-year results of the 3f Enable long-term follow-up study.
    Englberger L; Carrel TP; Doss M; Sadowski J; Bartus K; Eckstein FF; Asch FM; Martens S
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1681-7. PubMed ID: 24787699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis.
    Panchal HB; Ladia V; Amin P; Patel P; Veeranki SP; Albalbissi K; Paul T
    Am J Cardiol; 2014 Dec; 114(12):1882-90. PubMed ID: 25438917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.
    Husser O; Pellegrini C; Kessler T; Burgdorf C; Thaller H; Mayr NP; Ott I; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1809-16. PubMed ID: 26718512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sutureless versus conventional bioprostheses for aortic valve replacement in severe symptomatic aortic valve stenosis.
    Fischlein T; Folliguet T; Meuris B; Shrestha ML; Roselli EE; McGlothlin A; Kappert U; Pfeiffer S; Corbi P; Lorusso R;
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):920-932. PubMed ID: 33478837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcatheter versus surgical aortic-valve replacement in high-risk patients.
    Smith CR; Leon MB; Mack MJ; Miller DC; Moses JW; Svensson LG; Tuzcu EM; Webb JG; Fontana GP; Makkar RR; Williams M; Dewey T; Kapadia S; Babaliaros V; Thourani VH; Corso P; Pichard AD; Bavaria JE; Herrmann HC; Akin JJ; Anderson WN; Wang D; Pocock SJ;
    N Engl J Med; 2011 Jun; 364(23):2187-98. PubMed ID: 21639811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 71.